|Page (1) of 1 - 10/12/18||email article||print page|
(October 12, 2018)
NEW YORK, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, MD, Axsome’s Chief Executive Officer, will participate in two upcoming investor conferences:
- BIO 2018 Investor Forum, on October 17, 2018 at 2:30 PM Pacific Time. Dr. Tabuteau will present a corporate overview. The conference will be held at The Westin St. Francis in San Francisco, CA. A live webcast of this event can be viewed on the company’s website at www.axsome.com.
Related Sites: DMN Newswire , HTN - Health Technology Net
Related Newsletter: Tutorial Finder , Review Seeker , DMN Newswire Newsletter
Source:Copyright (c) GlobeNewswire, Inc. All Rights Reserved